ReviewJournal of the advanced practitioner in oncology

Subcutaneous Rituximab in Follicular Lymphoma, Chronic Lymphocytic Leukemia, and Diffuse Large B-Cell Lymphoma.

Bradley J YelvingtonPubMed ↗Full text ↗

No numbers read from the abstract.